Inheritor Cell Technology

ICT U.S.-Inheritor Cell Technology (USA) Inc. is a biotechnology company specializing in the research and the clinical application of stem cells. The company owns two modern research centers: the North American Regenerative Medicine Research Center and the China Clinical Application Center; both grand in scale and up to GMP standard. The American Center focuses on basic research, while the China Center focuses on clinical practice. The company has also established 80,000-sq-ft biobank (clinical-grade) in the Los Angeles area. ICT prides itself as multinational and one of the few pioneers within the regenerative medicine field with dual medical centers. We are devoted to providing services in stem cell manufacturing, clinical application, therapy and biologics; with a commitment to services in disease research, genetic tests, assisted reproduction, organ regeneration, genetic science, etc. The company has kept a large storage of human stem cells, tissues, organs, other biological samples within its clinical grade biobank for future medical research and development in applications. We are fully aware that within the ever-growing trend of artificial intelligence, the future has rendered machines to be smarter and that the future should not only render machines to be smarter, but the enhancement of health standards as well. We therefore insist that only healthy people are eligible to manage machines with greater intelligence. -Stem cells WILL change the lives of people.